214 related articles for article (PubMed ID: 15026339)
1. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity.
Miyazawa J; Mitoro A; Kawashiri S; Chada KK; Imai K
Cancer Res; 2004 Mar; 64(6):2024-9. PubMed ID: 15026339
[TBL] [Abstract][Full Text] [Related]
2. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of HMGA2, P16, and HPV in oral squamous cell carcinomas.
Loeschke S; Ohlmann AK; Bräsen JH; Holst R; Warnke PH
J Craniomaxillofac Surg; 2016 Sep; 44(9):1422-9. PubMed ID: 27421171
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
5. HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma.
Sakata J; Hirosue A; Yoshida R; Kawahara K; Matsuoka Y; Yamamoto T; Nakamoto M; Hirayama M; Takahashi N; Nakamura T; Arita H; Nakashima H; Nagata M; Hiraki A; Shinohara M; Nakayama H
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109142
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
7. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
8. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma.
Zhang H; Tang Z; Deng C; He Y; Wu F; Liu O; Hu C
Oral Dis; 2017 Mar; 23(2):255-264. PubMed ID: 27809392
[TBL] [Abstract][Full Text] [Related]
9. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
Hague A; Packham G; Huntley S; Shefford K; Eveson JW
J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
[TBL] [Abstract][Full Text] [Related]
10. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
[TBL] [Abstract][Full Text] [Related]
12. Stromelysin-3 expression is an early event in human oral tumorigenesis.
Soni S; Mathur M; Shukla NK; Deo SV; Ralhan R
Int J Cancer; 2003 Nov; 107(2):309-16. PubMed ID: 12949813
[TBL] [Abstract][Full Text] [Related]
13. HMGA2 is down-regulated by microRNA let-7 and associated with epithelial-mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs.
Liu Q; Liu T; Zheng S; Gao X; Lu M; Sheyhidin I; Lu X
Histopathology; 2014 Sep; 65(3):408-17. PubMed ID: 24612219
[TBL] [Abstract][Full Text] [Related]
14. Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis.
Yamazaki H; Mori T; Yazawa M; Maeshima AM; Matsumoto F; Yoshimoto S; Ota Y; Kaneko A; Tsuda H; Kanai Y
Lab Invest; 2013 Dec; 93(12):1331-8. PubMed ID: 24145240
[TBL] [Abstract][Full Text] [Related]
15. HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma.
Sterenczak KA; Eckardt A; Kampmann A; Willenbrock S; Eberle N; Länger F; Kleinschmidt S; Hewicker-Trautwein M; Kreipe H; Nolte I; Murua Escobar H; Gellrich NC
BMC Cancer; 2014 Sep; 14():694. PubMed ID: 25245141
[TBL] [Abstract][Full Text] [Related]
16. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
17. Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression.
Maeda G; Chiba T; Okazaki M; Satoh T; Taya Y; Aoba T; Kato K; Kawashiri S; Imai K
Int J Oncol; 2005 Dec; 27(6):1535-41. PubMed ID: 16273209
[TBL] [Abstract][Full Text] [Related]
18. Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma.
Grimm M; Alexander D; Munz A; Hoffmann J; Reinert S
Clin Exp Metastasis; 2013 Apr; 30(4):529-40. PubMed ID: 23184277
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of thrombomodulin in oral squamous cell carcinoma and its association with invasive and metastatic potential.
Tabata M; Sugihara K; Yonezawa S; Yamashita S; Maruyama I
J Oral Pathol Med; 1997 Jul; 26(6):258-64. PubMed ID: 9234185
[TBL] [Abstract][Full Text] [Related]
20. Prediction of occult lymph node metastasis in squamous cell carcinoma of the oral cavity and the oropharynx using peritumoral Prospero homeobox protein 1 lymphatic nuclear quantification.
Mermod M; Bongiovanni M; Petrova TV; Dubikovskaya EA; Simon C; Tolstonog G; Monnier Y
Head Neck; 2016 Sep; 38(9):1407-15. PubMed ID: 27043718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]